http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2046412-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56abb7a905b2aba4c53d3d3debee8c14
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-765
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-765
filingDate 1991-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c88ad329718b3ed5b42fc0f72f43be1
publicationDate 1992-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2046412-A1
titleOfInvention Treatment of inflammatory diseases with polyoxyethylenesorbitan mono-higher-fatty acid esters
abstract ABSTRACT The present invention is directed to a pharmaceutical composition for the treatment of inflammatory diseases comprising a polyoxyethylenesorbitan mono-higher-fatty acid ester in association with a pharmaceutically acceptable carrier, diluent or excipient.
priorityDate 1990-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454280487
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415967486
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425534311
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10467
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID103023
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426070965
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6144
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517430
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538474
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281119
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474480
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6354
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508097
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474481
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445638
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425188129
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5312402
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1978
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493215
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282767

Total number of triples: 35.